Extracellular-Matrix-Metalloproteinase-Inducer	NN
(	(
EMMPRIN	NN
)	)
promotes	VBZ
lung	NN
fibroblast	NN
proliferation	NN
,	,
survival	NN
and	CC
differentiation	NN
to	TO
myofibroblasts	NNS
.	.

BACKGROUND	NN
:	:
Idiopathic	JJ
pulmonary	JJ
fibrosis	NN
(	(
IPF	NN
)	)
is	VBZ
a	DT
chronic	JJ
progressively	RB
fatal	JJ
disease	NN
.	.

Extracellular-Matrix-Metalloproteinase-Inducer	NN
(	(
EMMPRIN	NN
)	)
is	VBZ
a	DT
glycosylated	VBN
transmembrane	NN
protein	NN
that	WDT
induces	VBZ
the	DT
expression	NN
of	IN
some	DT
matrix	NN
metalloproteinase	NN
(	(
MMP	NN
)	)
in	IN
neighboring	VBG
stromal	JJ
cells	NNS
through	IN
direct	JJ
epithelial-stromal	JJ
interactions	NNS
.	.

EMMPRIN	NNP
is	VBZ
highly	RB
expressed	VBN
in	IN
type	NN
II	CD
alveolar	JJ
epithelial	JJ
cells	NNS
at	IN
the	DT
edges	NNS
of	IN
the	DT
fibrotic	JJ
areas	NNS
in	IN
IPF	NN
lung	NN
sections	NNS
.	.

However	RB
,	,
the	DT
exact	JJ
role	NN
of	IN
EMMPRIN	NNP
in	IN
IPF	NNP
is	VBZ
unknown	JJ
.	.

METHODS	NNS
:	:
To	TO
determine	VB
if	IN
EMMPRIN	NNP
contributes	VBZ
to	TO
lung	NN
fibroblast	NN
proliferation	NN
,	,
resistance	NN
to	TO
apoptosis	NN
,	,
and	CC
differentiation	NN
to	TO
myofibroblasts	NNS
,	,
normal	JJ
Human	JJ
lung	NN
fibroblasts	NNS
(	(
NHLF	NN
)	)
transiently	RB
transfected	VBN
with	IN
either	CC
EMMPRIN/GFP	NN
or	CC
GFP	NN
were	VBD
treated	VBN
with	IN
TGF	NN
--	:
b1	NN
from	IN
0	CD
to	TO
10	CD
ng/ml	NN
for	IN
48	CD
h	NN
and	CC
examined	VBN
for	IN
cell	NN
proliferation	NN
(	(
thymidine	NN
incorporation	NN
)	)
,	,
apoptosis	NN
(	(
FACS	NN
analysis	NN
and	CC
Cell	NN
Death	NN
Detection	NN
ELISA	NN
assay	NN
)	)
,	,
cell	NN
migration	NN
(	(
Modified	VBN
Boyden	NN
chamber	NN
)	)
and	CC
differentiation	NN
to	TO
myofibroblasts	NNS
using	VBG
Western	NN
blot	NN
for	IN
a-smooth	JJ
actin	NN
of	IN
cell	NN
lysates	NNS
.	.

The	DT
effect	NN
of	IN
EMMPRIN	NN
inhibition	NN
on	IN
NHLF	NN
proliferation	NN
,	,
apoptosis	NN
,	,
migration	NN
and	CC
differentiation	NN
to	TO
myofibroblasts	NNS
after	IN
TGF	NN
--	:
b1	NN
treatment	NN
was	VBD
examined	VBN
using	VBG
EMMPRIN	NNP
blocking	VBG
antibody	NN
.	.

We	PRP
examined	VBD
the	DT
mechanism	NN
by	IN
which	WDT
EMMPRIN	NN
induces	VBZ
its	PRP$
effects	NNS
on	IN
fibroblasts	NNS
by	IN
studying	VBG
the	DT
b-catenin/canonical	JJ
Wnt	NN
signaling	NN
pathway	NN
using	VBG
Wnt	NN
luciferase	NN
reporter	NN
assays	NNS
and	CC
Western	NN
blot	NN
for	IN
total	JJ
and	CC
phosphorylated	JJ
b-catenin	NN
.	.

RESULTS	NNS
:	:
Human	JJ
lung	NN
fibroblasts	NNS
overexpressing	VBG
EMMPRIN	NNP
had	VBD
a	DT
significant	JJ
increase	NN
in	IN
cell	NN
proliferation	NN
and	CC
migration	NN
compared	VBN
to	TO
control	VB
fibroblasts	NNS
.	.

Furthermore	RB
,	,
EMMPRIN	NNP
promoted	VBD
lung	NN
fibroblasts	NNS
resistance	NN
to	TO
apoptosis	NN
.	.

Lung	NN
fibroblasts	NNS
overexpressing	VBG
EMMPRIN	NN
showed	VBD
a	DT
significantly	RB
increased	VBN
expression	NN
of	IN
a	DT
-	:
smooth	JJ
muscle	NN
actin	NN
,	,
a	DT
marker	NN
of	IN
differentiation	NN
to	TO
myofibroblasts	NNS
compared	VBN
to	TO
control	NN
cells	NNS
.	.

TGF-b1	NN
increased	VBD
the	DT
expression	NN
of	IN
EMMPRIN	NNP
in	IN
lung	NN
fibroblasts	NNS
in	IN
a	DT
dose-dependent	JJ
manner	NN
.	.

Attenuation	NN
of	IN
EMMPRIN	NN
expression	NN
with	IN
the	DT
use	NN
of	IN
an	DT
EMMPRIN	NN
blocking	VBG
antibody	NN
markedly	RB
inhibited	VBD
TGF-b1	NN
induced	VBD
proliferation	NN
,	,
migration	NN
,	,
and	CC
differentiation	NN
of	IN
fibroblasts	NNS
to	TO
myofibroblasts	NNS
.	.

EMMPRIN	NN
overexpression	NN
in	IN
lung	NN
fibroblasts	NNS
was	VBD
found	VBN
to	TO
induce	VB
an	DT
increase	NN
in	IN
TOPFLASH	NN
luciferase	NN
reporter	NN
activity	NN
when	WRB
compared	VBN
with	IN
control	JJ
fibroblasts	NNS
.	.

CONCLUSION	NN
:	:
These	DT
findings	NNS
indicate	VBP
that	IN
TGF-b1	NN
induces	VBZ
the	DT
release	NN
of	IN
EMMPRIN	NNP
that	WDT
activates	VBZ
b-catenin/canonical	JJ
Wnt	NN
signaling	NN
pathway	NN
.	.

EMMPRIN	NN
overexpression	NN
induces	VBZ
an	DT
anti-apoptotic	JJ
and	CC
pro-fibrotic	JJ
phenotype	NN
in	IN
lung	NN
fibroblasts	NNS
that	WDT
may	MD
contribute	VB
to	TO
the	DT
persistent	JJ
fibro-proliferative	JJ
state	NN
seen	VBN
in	IN
IPF	NN
.	.

